Editorial Comment on "Tolerability of immune checkpoint inhibitor doublet for advanced renal cell carcinoma patients with pre-dialysis chronic kidney disease or end-stage renal disease".
Syuya KandoriPublished in: International journal of urology : official journal of the Japanese Urological Association (2023)